Patents by Inventor Masaya Ono

Masaya Ono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250044122
    Abstract: To perform map synchronization in a manner more intuitive for a user.
    Type: Application
    Filed: October 27, 2022
    Publication date: February 6, 2025
    Inventors: MASAYA KANEKO, TATSUKI KASHITANI, YUKI ONO
  • Patent number: 8883972
    Abstract: The present invention provides an antibody, which reacts with a FGA or FGA partial peptide in which a part of prolines in the molecule thereof are hydroxylated, and which does not react with an unmodified FGA or FGA partial peptide.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: November 11, 2014
    Assignees: Transgenic Inc., President, National Cancer Center
    Inventors: Hiroshi Nose, Tomoyo Hashiguchi, Masaya Ono, Tesshi Yamada, Setsuo Hirohashi
  • Patent number: 8017732
    Abstract: A novel protein and a fragment thereof useful as a tumor marker of pancreatic cancer are disclosed. This protein or a fragment thereof is a modified ?-fibrinogen protein containing an oxidized amino acid residue(s) or a fragment thereof containing said oxidized amino acid residue(s). The oxidized amino acid residue(s) is one or more amino acid residues selected from the group consisting of (a) a proline residue corresponding to the proline residue at the position of 530 in SEQ ID NO: 2, and (b) a proline residue corresponding to the proline residue at the position of 565 in SEQ ID NO: 2.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: September 13, 2011
    Assignee: Japan Health Sciences Foundation
    Inventors: Masaya Ono, Tesshi Yamada, Setsuo Hirohashi
  • Publication number: 20110112278
    Abstract: A novel protein and a fragment thereof useful as a tumor marker of pancreatic cancer are disclosed. This protein or a fragment thereof is a modified ?-fibrinogen protein containing an oxidized amino acid residue(s) or a fragment thereof containing said oxidized amino acid residue(s). The oxidized amino acid residue(s) is one or more amino acid residues selected from the group consisting of (a) a proline residue corresponding to the proline residue at the position of 530 in SEQ ID NO: 2, and (b) a proline residue corresponding to the proline residue at the position of 565 in SEQ ID NO: 2.
    Type: Application
    Filed: July 24, 2008
    Publication date: May 12, 2011
    Inventors: Masaya Ono, Tesshi Yamada, Setsuo Hirohashi
  • Publication number: 20100092994
    Abstract: The present invention provides an antibody, which reacts with a FGA or FGA partial peptide in which a part of prolines in the molecule thereof are hydroxylated, and which does not react with an unmodified FGA or FGA partial peptide.
    Type: Application
    Filed: February 12, 2009
    Publication date: April 15, 2010
    Inventors: Hiroshi Nose, Tomoyo Hashiguchi, Masaya Ono, Tesshi Yamada, Setsuo Hirohashi